PrEP

B.C. approves coverage of HIV-blocking drug for high-risk groups

Activists are applauding the B.C. government for approving coverage of an HIV-prevention drug for those at high-risk of infection. On Thursday, the Ministry of Health announced that access to pre-exposure prophylaxis – better known as PrEP – will be free of charge beginning Jan. 1 for men and transwomen who have sex with men, injection […]

B.C. approves coverage of HIV-blocking drug for high-risk groups Read More »

B.C. offers free HIV prevention treatment to high-risk patients

Starting Jan. 1, the province will begin offering a powerful HIV prevention treatment for free through the B.C. Centre for Excellence in HIV/AIDS to high-risk individuals who ask for it, Health Minister Adrian Dix said Thursday. The prevention method involves a pill that combines two of the three anti-retroviral drugs used to treat HIV-infected patients,

B.C. offers free HIV prevention treatment to high-risk patients Read More »

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below